Legislators Target California Stem Cell Agency
The California stem cell agency may have believed its difficulties with the California legislature had vanished, but no such luck.
A bipartisan attempt is underway to change the composition of CIRM's Oversight Committee and dictate some terms of its intellectual property policies, among other things. The effort must be bipartisan because a colossal major…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.